Andres Sheppard at Cantor Fitzgerald said in an interview that he saw a couple of positives in the report that may have prompted investors to look past the miss. "I personally think the biggest positi ...
Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Free Report) – Cantor Fitzgerald issued their FY2025 earnings estimates for Arcturus Therapeutics in a report released on Tuesday ...
This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...
Cantor Fitzgerald analyst Jonathan Ruykhaver reiterated a Hold rating on Check Point (CHKP – Research Report) today and set a price target of $200.00. The company’s shares closed last Friday ...
Cantor Fitzgerald analyst Jonathan Ruykhaver tells investors that the firm’s checks on Check Point (CHKP) remain consistent and “encouraging,” suggesting improved near-term performance.
In preparation for the launch, Cantor Fitzgerald hosted a discussion with a Senior Director of Product Development at UnitedHealth (NYSE:UNH). The conversation provided insights into the coverage ...